Showing results (1-10 of 195) with videos related to

Sort By:
Pageof 20
Frontiers in Cardiovascular Medicine|February 20, 2025
Call for a consensual definition of dyslipidemia in coronary angiography trialsAurélien Clerc, Mario Togni, Stephane Cook
BMJ Case Reports|July 23, 2024
Valve-in-Valve-in-ValveSelma Tosca Cook, Mario Togni, Patrice Denervaud, et al.
Plos One|January 9, 2025
Futility in TAVI: A scoping review of definitions, predictive criteria, and medical predictive modelsCharlie Ferry, Jade Fiery-Fraillon, Mario Togni, et al.
Life (Basel, Switzerland)|March 28, 2026
First-in-Center Experience with a Novel Intravascular Lithotripsy System: The Shunmei ShockFast™ Intravascular Lithotripsy System Device for the Treatment of Severe Calcified Coronary De Novo LesionsGiacomo Maria Cioffi, Julius Jonas Jelisejevas, Ioannis Skalidis, et al.
Frontiers in Cardiovascular Medicine|September 26, 2024
Ten-year clinical outcomes of everolimus- and biolimus-eluting coronary stents vs. everolimus-eluting bioresorbable vascular scaffolds-insights from the EVERBIO-2 trialSamir Bengueddache, Malica Cook, Sonja Lehmann, et al.
BMC Cardiovascular Disorders|August 30, 2025
Predicting one-year outcomes after TAVI: evidence from a two-site Swiss registryCharlie Ferry, Dorian Garin, Roberto Corti, et al.
Journal of Clinical Medicine|December 11, 2025
AI-Automated Risk Operative Stratification for Severe Aortic Stenosis: A Proof-of-Concept StudyDorian Garin, Diego Arroyo, Ioannis Skalidis, et al.
The International Journal of Cardiovascular Imaging|June 13, 2026
Murray law-based quantitative flow ratio for functional assessment of coronary lesions: a systematic review and meta-analysisIoannis Skalidis, Wesley Bennar, Dorian Garin, et al.
Journal of the American College of Cardiology|July 19, 2005
Sirolimus-eluting stents associated with paradoxic coronary vasoconstrictionMario Togni, Stephan Windecker, Rosangela Cocchia, et al.
The American Journal of Cardiology|January 31, 2007
Effect of atorvastatin and pravastatin on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary stent thrombosisPeter Wenaweser, Stephan Windecker, Michael Billinger, et al.
Pageof 20